Clinical Trials Directory

Trials / Unknown

UnknownNCT01508507

Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine

Effectiveness of a Bivalent, Killed Whole-cell Based Oral Cholera Vaccine(Shanchol®) Delivered Through Community-based Mass Vaccination Campaign in a High-risk Population in India: Matched Case-control Studies

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
International Vaccine Institute · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers
Not accepted

Summary

Various field studies has found that the modified , bivalent, whole cell - based oral cholera vaccine (OCV) to be safe, immunogenic and effective with protective efficacy of 67 % in earlier clinical trials. However, the effectiveness of the vaccine in "real" life situation using the public health system is unknown. It is critical to follow up in the same population, where pilot introduction of OCV was introduced and evaluate vaccine proactive effectiveness at individual as well as at population level. The follow - up and determination of effectiveness of mass OCV vaccination was requested by State Government.

Detailed description

The overall goal of this study is to evaluate the protective effectiveness of one or two doses of modified, bivalent, killed whole cell based OCV, given at least 14 days apart, when delivered through community - based mass vaccination campaign using existing public health infrastructure in a high - risk population in Satyabadi block of Puri district, Orissa, India. This study has following objectives Primary objectives: \* To evaluate the individual level protective effectiveness of one or two doses of OCV against culture confirmed cholera episodes, severe enough to seek a formal health care. Secondary objectives: * To evaluate population - level effectiveness (herd effects)of OCV delivered through a community based mass vaccination when the vaccine is delivered to more than half of population at risk. * To determine inverse correlation between vaccine coverage and cholera incidence among diverse geographical clusters.

Conditions

Timeline

Start date
2013-03-01
Primary completion
2014-02-01
Completion
2014-03-01
First posted
2012-01-12
Last updated
2013-06-05

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01508507. Inclusion in this directory is not an endorsement.